Bodisen Biotech Hosted Institutional Investors in Yangling, Management to Conduct Investor Meetings in New York.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Bodisen Biotech, Inc., (AMEX AMEX See: American Stock Exchange :BBC BBC in full British Broadcasting Corp. Publicly financed broadcasting system in Britain. A private company at its founding in 1922, it was replaced by a public corporation under royal charter in 1927. , London AIM:BODI BODI Business Objects Data Integrator BODI Business of Diving Institute , website: www.bodisen.com) the first China-based environmentally friendly bio fertilizer company listed on a US stock exchange, and dually listed in London, today announced that the Bodisen management team, led by Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Karen Qiong Wang, hosted visits by institutional investors at the company's Yangling headquarters in China on May 18, 2006. The visit was joined by the company's board members and legal counsel from the US. The visitors toured Bodisen's facilities as well as conducted due diligence meetings Due Diligence Meeting The process of careful investigation by an underwriter to ensure that all material information pertinent to a security issue has been disclosed to prospective investors. with management. The Governor of Shaanxi Province also met with members of the delegation. Bodisen's management will be in New York during the week of May 22, 2006 to meet with other institutional investors. The company's Chairman and CEO Karen Qiong Wang and President Bo Chen will provide an overview of the company's business and operations and its financial results. Bodisen has reported record earnings for the first quarter of 2006 and has reaffirmed 2006 earnings guidance. A copy of the company's updated investor presentation will be available on the company's website at www.bodisen.com starting on May 22, 2006. Institutional investors may contact The Piacente Group, Bodisen's U.S. investor relations Investor relations The process by which the corporation communicates with its investors. counsel, at 212-481-2050 regarding the company's meeting schedules in New York. About Bodisen Biotech, Inc. A Delaware company, Bodisen is headquartered in the city of Yang Ling, Shaanxi Province, China's agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into four product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; Pesticides & Insecticides, and agricultural raw materials. Bodisen's organic fertilizers can be absorbed by plants within 48 hours and enrich soil conditions. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being environmentally friendly. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth in its existing business. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion